Quanterix Corporation

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. B+L Bolsters Ophthalmology With Acquis

The growing field of Alzheimer’s disease diagnostics is gaining another entrant with Quest Diagnostics Incorporated ’ new blood biomarker test for phosphorylated tau 217, or p-tau217. Research has sh

Roche Corp. ’s Elecsys pTau217 plasma biomarker test, which has been granted US Food and Drug Administration breakthrough device designation and was developed in partnership with Eli Lilly and Compan

Shares in Cassava Sciences have been hit again after lab services company Quanterix distanced itself from a row about the company’s controversial Alzheimer’s candidate simufilam. Cassava unveiled